Halo Pharmaceutical, ExxPharma partner to develop products using Twin Screw Extrusion technology Read more
Grünenthal selects Patheon to develop drugs using INTAC abuse deterrent formulations technology Read more
DNAtrix’s Oncolytic Immunotherapy, DNX-2401, Awarded EU Orphan Medicine Designation for Treating Malignant Brain Tumors Read more